Latest MedImmune Stories
NEW YORK, Dec.
Clinical Development, Manufacturing Expertise, and Scale Critical to Success WHITEHOUSE STATION, N.J. and AMES, IA, Nov.
MERIDEN, Conn., Oct. 29, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the U.S.
-- Studies will accelerate IND-enabling development of VesiculoVax(TM) Ebola vaccine -- BALTIMORE, Oct. 22, 2014 /PRNewswire/ -- Profectus BioSciences, Inc.
PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
Recent studies looking at the relationship between probiotics and the flu provide further evidence that probiotics are useful for the prevention of respiratory tract infections and boosting the
NEW YORK, Oct.
ITI has submitted a new IND for a Phase II clinical study of the JRC Vaccine Hershey, PA & Rockville, MD (PRWEB) October 01, 2014 DNA Vaccine pioneer
The U.S. Department of Health and Human Services will fund up to $12.9 million for the development of Alere's next-generation POC molecular influenza test WALTHAM, Mass., Oct.
The makers of FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) and the "CSI: Cyber" star launch national campaign to dispel common misconceptions about flu and annual vaccination
- A transitional zone between two communities containing the characteristic species of each.